Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Diabetes, Parkinson's
These Diabetes Drugs Could Help Lower Your Risk of Dementia, Parkinson’s
According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or SGLT2 inhibitors, stop the kidneys from reabsorbing too much blood glucose to improve blood sugar levels.
Some diabetes meds might lower risk of dementia, Parkinson's
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
Some diabetes drugs tied to lower risk of dementia, Parkinson's disease
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study.
Jardiance and other popular diabetes drugs may help prevent dementia
A new study shows people taking SGLT-2 inhibitors had fewer dementia cases than those taking DPP-4 inhibitors.
Type 2 drugs could lower dementia, Parkinson's disease risk
Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk of dementia, overall, and of Alzheimer's disease and Parkinson's, in particular.
ScienceAlert on MSN
9h
Common Diabetes Medication Slows Brain Aging in Monkeys
Metformin is the main first-line drug used to treat type 2 diabetes, but a new study on monkeys suggests it could one day be ...
2d
on MSN
GLP-1 pills are coming, and they could revolutionize weight-loss treatment
At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...
Lohud.com, Westchester County on MSN
2d
Do you want to take Wegovy, Ozempic in New York? Are you taking it now? Tell us your story
Nearly 4.4 million adult New Yorkers, or 30%, has obesity, but access to weight-loss medications varies based on a variety of ...
JD Supra
2d
Ozempic Lawsuit Update: New Study Links Semaglutides to Increased Risk of Vision Loss
More plaintiffs are continuing to join the diabetes drug Ozempic lawsuits against Novo Nordisk; and, until a couple of weeks ...
3d
on MSN
Ozempic might slow progression of diabetes-related liver disease
Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP ...
Medscape
4d
Will New Obesity Drugs Make Bariatric Surgery Obsolete?
Aronne, MD, of Weill Cornell Medicine in New York City, made a compelling case that the next generation of obesity ...
36m
on MSN
New blood test could be an early warning for child diabetes – study
New blood test could be an early warning for child diabetes – study - Scientists say that testing for fatty acids could make ...
Hoodline
2d
San Antonio Partners with H-E-B to Offer Financial Aid for Insulin Through New Diabetes Program
San Antonio and H-E-B launch an insulin assistance program providing up to $100 per prescription, with no insurance needed, ...
KAGS TV
2d
'It's frustrating' | Brazos Valley man says GLP-1 medications continue to be in short supply for diabetics
The demand for medications like Ozempic continues to cause shortages for both those seeking weight loss and patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback